Radiopharmaceuticals in Modern Cancer Therapy

  • Elliyanti A
N/ACitations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

Nuclear medicine plays a role in oncology. It uses tracers (radiopharmaceuti-cals) to study physiological processes and treat diseases. The radiopharmaceuticals can be formed as radionuclides alone or radionuclides labeled with other molecules as a drug, a protein, or a peptide. The radiopharmaceutical is introduced into the body and accumulates in the target tissue of interest for therapy or imaging purposes. It offers to study cancer biology in vivo to optimize cancer therapy. Another advantage of radiopharmaceutical therapy is a tumor-targeting agent that deposits lethal radiation at tumor sites. This review outlines radiopharmaceuticals agents in current cancer therapy.

Cite

CITATION STYLE

APA

Elliyanti, A. (2022). Radiopharmaceuticals in Modern Cancer Therapy. In Radiopharmaceuticals - Current Research for Better Diagnosis and Therapy. IntechOpen. https://doi.org/10.5772/intechopen.99334

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free